Based out of Cohort Innovation Space, LX Health has announced the 10 startups selected for its 2026 LuminaX HealthTech Accelerator.

Now in its sixth year, the 14-week accelerator supports some of Australia’s most promising healthtech, including medtechsportstech and biotech founders, guiding them through an intensive commercialisation program designed to fast-track growth and market readiness.

This year’s cohort highlights a clear shift in the sector towards preventative and functional health. Many of the selected startups are focused on early disease detection, improving ongoing health monitoring, and empowering individuals to take control of their wellbeing before illness develops.

The innovations span a wide range of applications. From a predictive blood test for postpartum depression, to a non-invasive AI-powered heart disease screening device, and gamified mental health programs for primary school students, this cohort reflects a growing belief that the most effective healthcare interventions happen before treatment is required.

LX Health Program Director Dren Xerxa said the 2026 intake marks a milestone for the program, both in scale and quality.

“What stands out is the number of founders building solutions that work upstream, focusing on prevention, early detection, and personalised monitoring. This is where the biggest opportunity lies, and it’s exciting to see Australian founders leading in this space.” Xerxa said.

Half of the successful applicants are female-led, something LX Health is proud to consistently see as founder diversity across the healthtech sector continues to grow.

The program is delivered in partnership with the Queensland Government through Economic Development Queensland, alongside Invest Gold Coast and QIC as major partners. Industry partners include Griffith University, the NRL, Gold Coast Hospital and Health Service, and the Gold Coast Health & Knowledge Precinct.

 

The 2026 LuminaX Participants are:

Ketim Technologies – Developing the world’s first predictive blood test for postpartum depression, combining multi-protein biomarkers and AI to identify at-risk mothers during pregnancy, before symptoms begin. ketim.com.au

CARED – An Australia-wide allied health and care platform that matches people to the right clinicians and carers, and delivers services with clinical governance, reporting, and a seamless digital experience. www.cared.io

Exonova Biotech – Revolutionising endometriosis diagnosis to help women access faster, more accurate answers to one of healthcare’s most under-diagnosed conditions. exonova.com.au

Gild – Rebuilding healthcare payments infrastructure to enable compliant gap-only payments and automated Medicare rebate routing, reducing upfront costs for patients while ensuring clinics are paid accurately and on time. gildhealth.com.au

Hormone Tracking System – A daily at-home hormone tracking device that helps predict energy levels and guide life, wellness, and training decisions, putting the power of hormonal health intelligence directly into people’s hands. hormonetrackingsystem.com

Mind Maze – Building preventative behavioural health infrastructure in primary schools through engaging, gamified learning that equips children with the tools to support their own mental wellbeing from an early age.

MyoIntel – We build athlete-specific digital twins that turn widely used team-sport data such as GPS and match-event coding into muscle-level workload insights for performance and injury management.

Nouscope – A governed AI reasoning platform that makes clinical AI deployable by ensuring every output is traceable to evidence, auditable, and defensible within regulated healthcare workflows. linkedin.com/company/nouscope

Sonorus – An impact-driven healthcare company building an AI-powered medical device to non-invasively screen for rheumatic heart disease, with a focus on reaching communities where access to diagnosis has historically been out of reach. sonorus.tech

Tolaris Labs – Patient-specific surgical digital twins for vascular intervention, procedural planning, and device-risk insight. https://toralislabs.com/ 

END.